文献速递口腔修复与种植

Lunasin对RANKL诱导RAW 264.7细胞破骨形成的影响

The Effect of Lunasin on Receptor Activator of Nuclear Factor Kappa-B Ligand-mediated Osteoclast Formation from RAW 264.7 Cells.
PubMed 文献 · J Endod · 2018-04-18

本研究首次探讨lunasin的抗骨吸收特性,用重组RANKL诱导小鼠单核细胞系RAW 264.7分化为成熟破骨细胞,以TRAP染色鉴定。细胞暴露于50、75、100 μmol/L活性或失活lunasin,结果显示所有活性lunasin组破骨细胞形成较对照组和失活lunasin组显著减少(P < .001)。

要点

  • 活性lunasin在50–100 μmol/L浓度下抑制RANKL诱导的破骨细胞形成。
  • 失活lunasin无此抑制作用,提示其活性构象与抑制效应相关。
  • lunasin作为潜在抗骨吸收剂值得后续研究评估。

核心结论

  • Lunasin能抑制RANKL诱导的RAW 264.7细胞破骨形成,提示其可作为潜在抗骨吸收剂供未来研究评估。

研究设计与样本

  • 体外研究,使用小鼠单核细胞系RAW 264.7在重组RANKL存在下诱导分化为成熟破骨细胞。
  • 细胞分为不同组,暴露于50 μmol/L、75 μmol/L和100 μmol/L的活性及失活lunasin,对照组为RANKL处理的RAW 264.7细胞。
  • 以抗酒石酸酸性磷酸酶(TRAP)染色鉴定破骨细胞,计数3个及以上核的TRAP阳性细胞,由3名观察者计数。
  • 数据采用单因素方差分析和Bonferroni校正事后多重比较分析。

主要发现

  • 所有活性lunasin组破骨细胞形成减少,与对照组相比差异有统计学意义(P < .001)。
  • 所有活性lunasin组破骨细胞形成减少,与失活lunasin组相比差异有统计学意义(P < .001)。

临床怎么用

  • 为lunasin作为抗骨吸收剂的后续研究提供体外证据,尚未推荐临床使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: To date, no study has investigated the antiresorptive property of lunasin. Hence, the present study aimed to assess the ability of lunasin to inhibit the osteoclast formation using RAW 264.7 cells. We hypothesized that lunasin is able to inhibit osteoclast formation. METHODS: In the present study, the murine monocytic cell line RAW 264.7 was induced to differentiate into mature osteoclasts in the presence of recombinant receptor activator of nuclear factor kappa-B ligand. Tartrate-resistant acid phosphatase, a marker of osteoclasts, was used to identify osteoclasts. Cell lines were divided into different groups and exposed to different concentrations of 50 μmol/L, 75 μmol/L, and 100 μmol/L active and inactive lunasin. The control group was RAW 264.7 cells with receptor activator of nuclear factor kappa-B ligand. Tartrate-resistant acid phosphatase-positive cells of 3 or more nuclei, indicative of mature osteoclasts, were counted by 3 observers. The mean number of the data collected was analyzed using 1-way analysis of variance and the multiple comparison post hoc Bonferroni correction. RESULTS: There was a significant difference in the reduction of osteoclast formation in all the active lunasin groups (P < .001) compared with the control group and the inactive lunasin group (P < .001). CONCLUSIONS: Considering the suppressive effect of lunasin on osteoclastogenesis, the use of lunasin as a potential antiresorptive agent can be evaluated in future studies.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Bachala D, El-Refai N, Greenfield E, et al. The Effect of Lunasin on Receptor Activator of Nuclear Factor Kappa-B Ligand-mediated Osteoclast Formation from RAW 264.7 Cells. J Endod. 2018. PMID: 29680727. doi:10.1016/j.joen.2018.02.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。